(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine ...

UltraTech Cement, Dr Reddy’s Labs, Hindustan Petroleum, Mphasis, Zee, Indus Towers, Adani Green Energy, Adani Energy ...

Shriram Finance is estimated to see strong YoY growth in its net profit and net interest income (NII) in Q3FY25, while a healthy rise in disbursement is expected to drive steady AUM growth.

IndiGo Q3 net profit is expected to see a sharp YoY fall due to costs associated with Aircraft on Ground (AoG) which have led to higher aircraft lease rentals, depreciation, and financing expenses.

Dr Reddy’s Laboratories reports 2% increase in net profit, attributing growth to new acquisitions and product launches.

The third-quarter earnings season is in full swing, with around 59 companies set to release their results on Thursday.

Indian Energy Exchange (IEX) rose 2.99% to Rs 172.50 after the company's consolidated net profit jumped 16.86% to Rs 107.29 crore on 14.53% increase in revenue from operations to Rs 132.05 crore in Q3 ...

Torrent Pharma, IndiGo parent InterGlobe Aviation, Godrej Consumer Products, JSW Steel, and Bank of India are among few of the key firms that will report Q3 results today. Track updates here ...

Indus Towers added 1.24% to Rs 371.95 after the telecom infrastructure provider's consolidated net profit climbed 159.9% to Rs 4,003.20 crore in Q3 FY25 as against Rs 1,540.50 crore posted in Q3 FY24.

The stock slumped 9 per cent to hit a low of Rs 994.05 over its previous close of Rs 1096.75. Market cap of the Tata Group ...